appScorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Granules India Ltd
GRANULES
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Analysts have suggested that investors can buy this stock
Company Profile
Granules India Limited is a pharmaceutical company that manufactures finished dosages (FDs), pharmaceutical formulation intermediates (PFIs) and active pharmaceutical ingredients (APIs).
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Zydus Lifesciences Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Increased Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has increased by 2.07%
Recent NewsAll news
Technical Breakout Stocks: How to trade Zomato, Gillette India, and Granules India on Monday - Market Summary
1 month ago•Economic Times
Technical Breakout Stocks: How to trade Torrent Power, Suven Pharma and Granules India on Thursday - Market Summary
1 month ago•Economic Times
Torrent Power Ltd leads gainers in ‘A’ group
1 month ago•Business Standard
Recent EventsAll events
Press Release
Granules India Limited has informed the Exchange regarding a press release dated September 07, 2024, titled "Granules India s Gagillapur Facility Completes US FDA Inspection with Six Observations". | Download
Granules India Limited has informed the Exchange regarding a press release dated September 07, 2024, titled "Granules India s Gagillapur Facility Completes US FDA Inspection with Six Observations". | Download
Press Release
Granules India Limited has informed the Exchange regarding a press release dated August 20, 2024, titled "Granules India Limited Receives ANDA Approval for Glycopyrrolate Oral Solution ". | Download
Granules India Limited has informed the Exchange regarding a press release dated August 20, 2024, titled "Granules India Limited Receives ANDA Approval for Glycopyrrolate Oral Solution ". | Download
Cash Dividend
Final • Div/Share: ₹ 1.5
Decreased Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has decreased by 3.10%